Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer | Breast Cancer | JAMA Oncology | JAMA Network

Share on facebook
Share on twitter
Share on linkedin

Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer | Breast Cancer | JAMA Oncology | JAMA Network

This validation study assesses the clinical validity of molecular relapse detection with circulating tumor DNA analysis in early-stage breast cancer.

Source: jamanetwork.com